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Abstract 
The treatment of cancer is becoming more precise, targeting specific oncogenic drivers with targeted 
molecular therapies. The epidermal growth factor receptor has been found to be over-expressed in a 
multitude of solid tumours. Immunohistochemistry is widely used in the fields of diagnostic and 
personalised medicine to localise and visualise disease specific proteins. To date the clinical utility 
of epidermal growth factor receptor immunohistochemistry in determining monoclonal antibody 
efficacy has remained somewhat inconclusive. The lack of an agreed reproducible scoring criteria 
for epidermal growth factor receptor immunohistochemistry has, in various clinical trials yielded 
conflicting results as to the use of epidermal growth factor receptor immunohistochemistry assay as 
a companion diagnostic. This has resulted in this test being removed from the licence for the drug 
panitumumab and not performed in clinical practice for cetuximab. In this review we explore the 
reasons behind this with a particular emphasis on colorectal cancer, and to suggest a way of 
resolving the situation through improving the precision of epidermal growth factor receptor 
immunohistochemistry with quantitative image analysis of digitised images complemented with 
companion molecular morphological techniques such as in situ hybridisation and section based gene 
mutation analysis. 
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